Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1246179.RA5W3yiD3P_INospog7enXoP234RzEmch0k1a2Ch8RTDI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1246179.RA5W3yiD3P_INospog7enXoP234RzEmch0k1a2Ch8RTDI130_assertion type Assertion NP1246179.RA5W3yiD3P_INospog7enXoP234RzEmch0k1a2Ch8RTDI130_head.
- NP1246179.RA5W3yiD3P_INospog7enXoP234RzEmch0k1a2Ch8RTDI130_assertion description "[Overexpression of GYS1, MIF, and MYC is associated with adverse outcome and poor response to azacitidine in myelodysplastic syndromes and acute myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1246179.RA5W3yiD3P_INospog7enXoP234RzEmch0k1a2Ch8RTDI130_provenance.
- NP1246179.RA5W3yiD3P_INospog7enXoP234RzEmch0k1a2Ch8RTDI130_assertion evidence source_evidence_literature NP1246179.RA5W3yiD3P_INospog7enXoP234RzEmch0k1a2Ch8RTDI130_provenance.
- NP1246179.RA5W3yiD3P_INospog7enXoP234RzEmch0k1a2Ch8RTDI130_assertion SIO_000772 25487600 NP1246179.RA5W3yiD3P_INospog7enXoP234RzEmch0k1a2Ch8RTDI130_provenance.
- NP1246179.RA5W3yiD3P_INospog7enXoP234RzEmch0k1a2Ch8RTDI130_assertion wasDerivedFrom befree-2016 NP1246179.RA5W3yiD3P_INospog7enXoP234RzEmch0k1a2Ch8RTDI130_provenance.
- NP1246179.RA5W3yiD3P_INospog7enXoP234RzEmch0k1a2Ch8RTDI130_assertion wasGeneratedBy ECO_0000203 NP1246179.RA5W3yiD3P_INospog7enXoP234RzEmch0k1a2Ch8RTDI130_provenance.